Healthcare Sector
Market Tracker
Represents the strikes that had the highest premium of whale flow (on the ASK side) over the past 5 trading days.
Represents the strikes that had the highest premium of whale flow (on the BID side) over the past 5 trading days.
Total Open Interest of Calls & Puts across all strikes and expirations over the past 16 trading days.
| Expires | Type | Strike | OI | Change | Percent |
|---|---|---|---|---|---|
| 12/18/2026 | PUT | $30.00 | 140 | +133 | +1,900.00% |
| 12/18/2026 | PUT | $40.00 | 135 | +125 | +1,250.00% |
| 12/18/2026 | CALL | $65.00 | 117 | +101 | +631.25% |
| 12/18/2026 | CALL | $60.00 | 81 | +81 | |
| 04/17/2026 | CALL | $42.00 | 109 | +63 | +136.96% |
| 05/15/2026 | CALL | $60.00 | 52 | +52 | |
| 04/17/2026 | CALL | $50.00 | 56 | -5 | -8.20% |
| 04/17/2026 | CALL | $40.00 | 97 | -6 | -5.83% |
| 09/18/2026 | CALL | $40.00 | 30 | -7 | -18.92% |
| 04/17/2026 | PUT | $30.00 | 1,398 | -19 | -1.34% |
| 06/18/2026 | CALL | $43.00 | 0 | -40 | -100.00% |
| 04/17/2026 | PUT | $35.00 | 232 | -56 | -19.44% |
Contracts with largest changes in open interest from the previous trading day to the current/most recent.
| Name | Pct Held | Shares | Total |
|---|---|---|---|
| Vanguard Total Stock Market Index Fund | 1.87% | 980.49k | 7.16M |
| Federated Hermes MDT Small Cap Core Fund | 1.51% | 792.28k | 5.78M |
| iShares Russell 2000 ETF | 1.37% | 717.67k | 5.24M |
| BlackRock Advantage Small Cap Core Fund | 0.90% | 471.78k | 3.44M |
| Vanguard Extended Market Index Fund | 0.89% | 463.98k | 3.39M |
| iShares NASDAQ Biotechnology ETF | 0.75% | 394k | 2.88M |
| iShares Russell 2000 Value ETF | 0.63% | 330.18k | 2.41M |
| Price (T.Rowe) Health Sciences Fund | 0.59% | 311.26k | 2.27M |
| Lincoln VIP Tr-SSgA Small Mid Cap 200 Fund | 0.57% | 299.97k | 2.19M |
| Fidelity Small Cap Index Fund | 0.52% | 273.62k | 2M |
Ameresco, Lithium Americas, Kodiak Sciences And Other Big Stocks Moving Higher On Thursday
09/25 10:34 am
Benzinga
Read moreDiabetic Retinopathy Global Clinical Trials Review 2024: Region, country (G7 & E7), phase, trial status, End-points Status and Sponsor Type
01/10 10:35 am
GlobeNewswire Inc.
Read moreShould You Hold Kodiak Sciences (KOD) Stock in Your Portfolio?
06/20 08:23 am
Zacks Investment Research
Read moreWhy Is Kodiak Sciences (KOD) Down 26.2% Since Last Earnings Report?
06/14 11:30 am
Zacks Investment Research
Read moreKodiak (KOD) Q1 Loss Narrower Than Expected, Pipeline in Focus
05/16 12:51 pm
Zacks Investment Research
Read moreKodiak (KOD) Counts on Tarcocimab Program Despite Setbacks
04/04 12:09 pm
Zacks Investment Research
Read moreKodiak (KOD) Stock Falls on Q4 Earnings Miss, Pipeline in Focus
04/01 12:00 pm
Zacks Investment Research
Read moreTake the Zacks Approach to Beat the Market: NVIDIA, Dell, Modine in Focus
04/01 08:03 am
Zacks Investment Research
Read moreUS Stocks Flat; Initial Jobless Claims Fall To 210,000
03/28 10:32 am
Benzinga
Read moreMerck (MRK) Unit to Buy Elanco's Aqua Business for $1.3B
02/06 11:49 am
Zacks Investment Research
Read moreVertex's (VRTX) Q4 Earnings and Sales Surpass Estimates
02/06 11:26 am
Zacks Investment Research
Read moreTEVA Q4 Earnings and Revenues Surpass Estimates, Stock Up
02/01 12:51 pm
Zacks Investment Research
Read moreBiogen (BIIB) to Stop Selling Alzheimer's Disease Drug Aduhelm
02/01 11:27 am
Zacks Investment Research
Read moreDr. Reddy's (RDY) Q3 Earnings and Revenues Surpass Estimates
02/01 10:03 am
Zacks Investment Research
Read moreKodiak Sciences Inc. (KOD) Up 43.6% Since Last Earnings Report: Can It Continue?
12/14 12:30 pm
Zacks Investment Research
Read moreEyePoint (EYPT) Surges 178% on Upbeat Phase II Eye Disease Data
12/05 10:18 am
Zacks Investment Research
Read moreKodiak (KOD) Beats Q3 Earnings, Provides Pipeline Updates
11/15 09:00 am
Zacks Investment Research
Read moreDow Jones secures longest win streak since late July following best week of 2023
11/06 05:36 pm
MarketWatch
Read moreKodiak Sciences Inc. (KOD) Down 19.9% Since Last Earnings Report: Can It Rebound?
09/13 11:30 am
Zacks Investment Research
Read moreKodiak (KOD) Q2 Earnings Miss, New Lead Candidate in Focus
08/16 10:26 am
Zacks Investment Research
Read moreShould You Buy Kodiak Sciences (KOD) Ahead of Earnings?
08/14 08:34 am
Zacks Investment Research
Read more3 Biotech Stocks Poised to Beat Q2 Earnings Estimates
08/14 07:15 am
Zacks Investment Research
Read moreLigand (LGND) to Post Q2 Earnings: What's in Store?
08/07 09:02 am
Zacks Investment Research
Read moreEli Lilly (LLY) to Report Q2 Earnings: What's in the Cards?
08/02 10:09 am
Zacks Investment Research
Read moreExpert Ratings for Kodiak Sciences
07/27 05:00 pm
Benzinga
Read moreBenzinga's Top Ratings Upgrades, Downgrades For July 27, 2023
07/27 11:00 am
Benzinga
Read moreBiotech Stock Roundup: BIIB, GSK's Q2 Earnings, KOD Faces Setback & More
07/26 10:08 am
Zacks Investment Research
Read moreKodiak Sciences Faces Downgrade Following Failed GLEAM And GLIMMER Studies
07/25 03:46 pm
Benzinga
Read moreBenzinga's Top Ratings Upgrades, Downgrades For July 25, 2023
07/25 11:00 am
Benzinga
Read moreKodiak (KOD) Down as Late-Stage DME Studies Fail
07/25 09:16 am
Zacks Investment Research
Read moreCrude Oil Rises Over 2%; US Composite PMI Falls In July
07/24 12:43 pm
Benzinga
Read moreBenzinga's Top Ratings Upgrades, Downgrades For July 24, 2023
07/24 11:00 am
Benzinga
Read moreDow Surges 150 Points; Domino's Pizza Earnings Top Expectations
07/24 10:45 am
Benzinga
Read moreWhy Is Kodiak Sciences Inc. (KOD) Up 62.9% Since Last Earnings Report?
06/14 11:30 am
Zacks Investment Research
Read moreZscaler, MongoDB, Chemours And Other Big Stocks Moving Higher On Friday
06/02 11:02 am
Benzinga
Read moreKodiak (KOD) Advances With Tarcocimab Amid Stiff Competition
05/30 11:14 am
Zacks Investment Research
Read moreVectivBio Holding, Greenhill, Atea Pharmaceuticals And Other Big Stocks Moving Higher On Monday
05/22 10:31 am
Benzinga
Read moreKodiak's (KOD) Q1 Earnings Miss, Pipeline in Focus, Stock Up
05/16 07:44 am
Zacks Investment Research
Read moreWhy Is Kodiak Sciences Inc. (KOD) Down 26.3% Since Last Earnings Report?
04/27 11:30 am
Zacks Investment Research
Read moreImmunic's (IMUX) Ulcerative Colitis Study Shows Positive Data
04/06 02:10 pm
Zacks Investment Research
Read morePalisade (PALI) Enrolls First Patient in LB1148 Study in China
04/06 02:09 pm
Zacks Investment Research
Read more